Philadelphia Jury Slaps GSK With $2.5M Paxil Verdict

Law360, New York (October 13, 2009, 3:00 PM EDT) -- A Philadelphia jury on Tuesday returned a $2.5 million verdict against GlaxoSmithKline in a product liability case alleging that 3-year-old Lyam Kilker was born with a rare heart defect as a result of his mother’s use of Paxil during pregnancy.

Within hours of the 10-2 verdict in the Philadelphia Court of Common Pleas, the drugmaker, part of U.K.-based pharmaceutical giant SmithKline Beecham Corp., said it would appeal.

"While we sympathize with Lyam Kilker and his family, the scientific evidence does not establish that exposure to Paxil...
To view the full article, register now.